Concepedia
Statistics
Publications
11
Citations
300
H-Index
10
Active since
2011
Affiliations
Chugai Pharma (United States)(Current)
Tokai University
Ken Aizawa is an author at Chugai Pharma (United States) specializing in medicine, physiology, and vascular biology.
Top concepts
MedicinePhysiologyPharmacologyVascular BiologyHealthNephrologyInflammationOsteoporosisEndocrinologyBone Metabolism
Publications per year
2011–2015
Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats
Kenichi Serizawa, Kenji Yogo, Ken Aizawa et al. · Cardiovascular Diabetology · 2011 · 64 citations · Full text
22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy
Michinori Hirata, Kenichi Serizawa, Ken Aizawa et al. · Nephrology Dialysis Transplantation · 2012 · 61 citations
Vitamin D Receptor Signaling Enhances Locomotive Ability in Mice
Sadaoki Sakai, Miho Suzuki, Yoshihito Tashiro et al. · Journal of Bone and Mineral Research · 2014 · 49 citations · Full text
Orthopaedic Surgery, Osteoporosis, Cellular Physiology +16
Paclitaxel-Induced Endothelial Dysfunction in Living Rats Is Prevented by Nicorandil via Reduction of Oxidative Stress
Kenichi Serizawa, Kenji Yogo, Ken Aizawa et al. · Journal of Pharmacological Sciences · 2012 · 26 citations · Full text
Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation
Ken Aizawa, Youko Takahari, Naoko Higashijima et al. · Journal of Pharmacological Sciences · 2015 · 26 citations · Full text
1–5 of 11